SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Commonwealth Income & Growth Fund V – ‘10-Q’ for 6/30/22 – ‘R4’

On:  Tuesday, 8/23/22, at 10:13am ET   ·   For:  6/30/22   ·   Accession #:  1654954-22-11685   ·   File #:  333-108057

Previous ‘10-Q’:  ‘10-Q’ on 5/18/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/29/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/23/22  Commonwealth Income & Growth Fd V 10-Q        6/30/22   46:1.7M                                   Blueprint/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    373K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     15K 
11: R1          Cover                                               HTML     64K 
12: R2          Condensed Balance Sheets                            HTML     85K 
13: R3          Condensed Balance Sheets (Parenthetical)            HTML     20K 
14: R4          Condensed Statements of Operations (Unaudited)      HTML     72K 
15: R5          Condensed Statement of Partners' Equity             HTML     43K 
                (Unaudited)                                                      
16: R6          Condensed Statements of Cash Flow (Unaudited)       HTML     30K 
17: R7          Business                                            HTML     22K 
18: R8          Summary of Significant Accounting Policies          HTML     28K 
19: R9          Information Technology, Medical Technology,         HTML     26K 
                Telecommunications Technology, Inventory                         
                Management and Other Business-Essential Capital                  
                Equipment ("Equipment")                                          
20: R10         Related Party Transactions                          HTML     33K 
21: R11         Notes Payable                                       HTML     29K 
22: R12         Supplemental Cash Flow Information                  HTML     20K 
23: R13         Commitments and Contingencies                       HTML     27K 
24: R14         Summary of Significant Accounting Policies          HTML     33K 
                (Policies)                                                       
25: R15         Summary of Significant Accounting Policies          HTML     19K 
                (Tables)                                                         
26: R16         Information Technology, Medical Technology,         HTML     21K 
                Telecommunications Technology, Inventory                         
                Management and Other Business-Essential Capital                  
                Equipment ("Equipment") (Tables)                                 
27: R17         Related Party Transactions (Tables)                 HTML     31K 
28: R18         Notes Payable (Tables)                              HTML     26K 
29: R19         Supplemental Cash Flow Information (Tables)         HTML     19K 
30: R20         Business (Details Narrative)                        HTML     19K 
31: R21         Summary of Significant Accounting Policies          HTML     20K 
                (Details)                                                        
32: R22         Summary of Significant Accounting Policies          HTML     18K 
                (Details Narrative)                                              
33: R23         Information Technology Medical Technology           HTML     27K 
                Telecommunications Technology Inventory Management               
                Equipment and other BusinessEssential Capital                    
                Equipment (Equipment) (Details)                                  
34: R24         Information Technology Medical Technology           HTML     24K 
                Telecommunications Technology Inventory Management               
                Equipment and other BusinessEssential Capital                    
                Equipment (Equipment) (Details Narrative)                        
35: R25         Related Party Transactions (Details)                HTML     21K 
36: R26         Related Party Transactions (Details Narrative)      HTML     26K 
37: R27         Notes Payable (Details)                             HTML     22K 
38: R28         Notes Payable (Details 1)                           HTML     26K 
39: R29         Notes Payable (Details Narrative)                   HTML     16K 
40: R30         Supplemental Cash Flow Information (Details)        HTML     17K 
41: R31         Commitments and Contingencies (Details Narrative)   HTML     37K 
44: XML         IDEA XML File -- Filing Summary                      XML     77K 
42: XML         XBRL Instance -- cigf5_10q_htm                       XML    291K 
43: EXCEL       IDEA Workbook of Financial Reports                  XLSX     60K 
 8: EX-101.CAL  XBRL Calculations -- cigf5-20220630_cal              XML     76K 
10: EX-101.DEF  XBRL Definitions -- cigf5-20220630_def               XML     94K 
 7: EX-101.LAB  XBRL Labels -- cigf5-20220630_lab                    XML    323K 
 9: EX-101.PRE  XBRL Presentations -- cigf5-20220630_pre             XML    241K 
 6: EX-101.SCH  XBRL Schema -- cigf5-20220630                        XSD     84K 
45: JSON        XBRL Instance as JSON Data -- MetaLinks              151±   204K 
46: ZIP         XBRL Zipped Folder -- 0001654954-22-011685-xbrl      Zip     93K 


‘R4’   —   Condensed Statements of Operations (Unaudited)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
 <>  v3.22.2.2
Condensed Statements of Operations (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Revenue        
Lease $ 38,440 $ 55,691 $ 84,534 $ 116,532
Interest and other 328 0 418 34
Sales and property taxes 1,321 2,527 2,597 5,189
Gain on sale of equipment 0 15,325 0 10,245
Total revenue and gain on sale of equipment 40,089 73,543 87,549 132,000
Expenses        
Operating, excluding depreciation and amortization 68,078 52,252 112,121 126,830
Interest 164 222 343 535
Depreciation 17,940 26,856 35,880 60,653
Sales and property taxes 1,321 2,527 2,597 5,189
Bad debt recovery 0 0 0 0
Total expenses 87,502 81,857 150,940 193,207
Net Loss (47,413) (8,314) (63,391) (61,207)
Net Loss allocated to Limited Partners $ (47,413) $ (8,314) $ (63,391) $ (61,207)
Net Loss per equivalent Limited Partnership unit $ (0.04) $ (0.01) $ (0.05) $ (0.05)
Weighted average number of equivalent limited        
partnership units outstanding during the period 1,233,244 1,234,748 1,233,354 1,235,006

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/23/22
For Period end:6/30/22NT 10-Q
6/30/2110-Q,  NT 10-Q
 List all Filings 
Top
Filing Submission 0001654954-22-011685   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 1:37:34.1pm ET